Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
P K Plant a Department of Respiratory Medicine, St James's
University Hospital, Leeds LS9 7TF, b Centre for
Health Economics, University of York, York YO10 5DD
Correspondence to:
P K Plant
Objective:
To evaluate the cost effectiveness of
standard treatment with and without the addition of ward based
non-invasive ventilation in patients admitted to hospital with an acute
exacerbation of chronic obstructive pulmonary disease.
What is already known on this topic
The procedure is feasible in the ward or intensive care environment What this study adds
The early use of non-invasive ventilation on the ward reduces costs and
improves outcomes compared with traditional medical treatment The main cost saving is in preventing the use of intensive care
facilities
paul.plant{at}leedsth.nhs.uk
Design:
Incremental cost effectiveness analysis of a
randomised controlled trial.
Setting:
Medical wards in 14 hospitals in the United Kingdom.
Participants:
The trial comprised 236 patients
admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease and mild to moderate acidosis (pH 7.25-7.35) secondary to respiratory failure. The economic analysis compared the
costs of treatment that these patients received after randomisation.
Main outcome measure:
Incremental cost per
in-hospital death.
Results:
24/118 died in the group receiving standard treatment and 12/118 in the group receiving non-invasive ventilation (P=0.05). Allocation to the group receiving non-invasive ventilation was associated with a reduction in costs of £49 362 ($78 741;
73 109), mainly through reduced use of intensive care units. The
incremental cost effectiveness ratio was
£645 per death avoided (95% confidence interval
£2310 to £386), indicating a dominant (more effective and less costly) strategy. Modelling of these data
indicates that a typical UK hospital providing a non-invasive ventilation service will avoid six deaths and three to nine admissions to intensive care units per year, with an associated cost reduction of
£12 000-53 000 per year.
Conclusions:
Non-invasive ventilation is a highly
cost effective treatment that both reduced total costs and improved mortality in hospital.
Non-invasive ventilation reduces the need for intubation and mortality
in hospital in patients with acute exacerbations of chronic obstructive
pulmonary disease and acute respiratory failure
Non-invasive ventilation given on wards reduces the need for intubation
by 44% and halves mortality in hospital in patients with chronic
obstructive pulmonary disease and mild to moderate acidosis
Read all Rapid Responses